Dunn permanent successor to Katz at FDA neurology division

William Dunn has been promoted to director of FDA's Division of Neurology Products

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE